Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$20.31 +0.12 (+0.59%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) Change in Accured Expenses (2010 - 2026)

Updated

Acadia Pharmaceuticals' Change in Accured Expenses was $22.53 million in Q2 2026, up 5.0% from $21.47 million a year earlier but down 4.4% from the prior quarter.

Analysis

Acadia Pharmaceuticals (ACAD) Change in Accured Expenses (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Acadia Pharmaceuticals' Change in Accured Expenses was $5.47 million through Jun 30, 2026, down 91.6% year-over-year; for FY2025, it was -$19.27 million.

  • In earlier years, Change in Accured Expenses was $71.06 million in FY2024 (-23.7%), $93.17 million in FY2023 (+283.3%), $24.31 million in FY2022 and -$8.46 million in FY2021.
  • Quarterly Change in Accured Expenses has moved between -$68.39 million (Q4 2025) and $38.13 million (Q4 2023) over five years.
  • Compared with a year earlier, Change in Accured Expenses was higher in three of the last five quarters, with growth averaging 17.4%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q1 2022 (growth of 612.5%); the worst was Q3 2024 (a decline of 53.0%).
  • Per Business Quant data, ACAD's Change in Accured Expenses in the three quarters before Q2 2026 was $23.56 million (Q1 2026), -$68.39 million (Q4 2025) and $27.78 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,148.60 Bn 1,117.19 Bn 19.71 Bn -
2 Johnson & Johnson 637.24 Bn 557.10 Bn 17.30 Bn 2.41 Bn
3 AbbVie 502.40 Bn 475.51 Bn 12.70 Bn 1.20 Bn
4 Merck 356.72 Bn 311.10 Bn 12.21 Bn -
5 Novartis Ag 301.65 Bn 265.64 Bn 11.24 Bn -
6 Astrazeneca 265.03 Bn 238.72 Bn 12.86 Bn -
7 Amgen 239.14 Bn 194.54 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 194.82 Bn 169.02 Bn 6.22 Bn 338.00 Mn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn -
10 Acadia Pharmaceuticals 3.43 Bn -40.86 Mn 279.64 Mn 22.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.53 Mn
Mar 31, 2026 23.56 Mn
Dec 31, 2025 -68.39 Mn
Sep 30, 2025 27.78 Mn
Jun 30, 2025 21.47 Mn
Mar 31, 2025 -116,000.00
Dec 31, 2024 30.78 Mn
Sep 30, 2024 13.24 Mn
Jun 30, 2024 14.85 Mn
Mar 31, 2024 12.19 Mn
Dec 31, 2023 38.13 Mn
Sep 30, 2023 28.16 Mn
Jun 30, 2023 2.37 Mn
Mar 31, 2023 24.51 Mn
Dec 31, 2022 6.54 Mn
Sep 30, 2022 917,000.00
Jun 30, 2022 -2.82 Mn
Mar 31, 2022 19.67 Mn
Dec 31, 2021 8.81 Mn
Sep 30, 2021 -5.93 Mn
API Access

Acadia Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ACAD&period=max&api_key=YOUR_API_KEY